Miev Y Carhart1, Donna L Schminkey1, Emma M Mitchell1, Jessica Keim-Malpass2. 1. University of Virginia School of Nursing, Charlottesville, VA, USA. 2. University of Virginia School of Nursing, Charlottesville, VA, USA; University of Virginia School of Medicine, Department of Pediatrics, Charlottesville, VA, USA. Electronic address: Jlk2t@virginia.edu.
Abstract
PURPOSE: Despite the evidence, the availability since 2006, and strong recommendations from many professional organizations, the human papillomavirus (HPV) vaccine has had a low uptake rate nationally and these trends have been even lower in the state of Virginia. DESIGN AND METHODS: We explored key stakeholders' perspectives on factors influencing HPV vaccination in central and southern Virginia organized within the socio-ecological model (SEM) framework. We conducted semi-structured key informant interviews with 31 stakeholders involved in HPV vaccination or cancer prevention. RESULTS: Stakeholders identified barriers at all SEM levels: Knowledge gaps and sexuality concerns (parent-child dyad level), time constraint and inconsistent recommendation (interpersonal level), lack of leadership and informational support (organizational and community level), and an ineffective mandate (policy level). Facilitators identified were realistic/receptive attitude (parent-child dyad level), provider's strong recommendation and educational support (interpersonal level), team approach and useful data (organizational level), educational outreach and community resources (community level), and support from federal and professional organizations (policy level). CONCLUSIONS: The stakeholder analysis provided an environmental scan of the barriers and facilitators so that an effective HPV vaccination strategy can be planned and implemented in the Commonwealth of Virginia by public health nurses.
PURPOSE: Despite the evidence, the availability since 2006, and strong recommendations from many professional organizations, the human papillomavirus (HPV) vaccine has had a low uptake rate nationally and these trends have been even lower in the state of Virginia. DESIGN AND METHODS: We explored key stakeholders' perspectives on factors influencing HPV vaccination in central and southern Virginia organized within the socio-ecological model (SEM) framework. We conducted semi-structured key informant interviews with 31 stakeholders involved in HPV vaccination or cancer prevention. RESULTS: Stakeholders identified barriers at all SEM levels: Knowledge gaps and sexuality concerns (parent-child dyad level), time constraint and inconsistent recommendation (interpersonal level), lack of leadership and informational support (organizational and community level), and an ineffective mandate (policy level). Facilitators identified were realistic/receptive attitude (parent-child dyad level), provider's strong recommendation and educational support (interpersonal level), team approach and useful data (organizational level), educational outreach and community resources (community level), and support from federal and professional organizations (policy level). CONCLUSIONS: The stakeholder analysis provided an environmental scan of the barriers and facilitators so that an effective HPV vaccination strategy can be planned and implemented in the Commonwealth of Virginia by public health nurses.
Authors: Richard A Crosby; Baretta R Casey; Robin Vanderpool; Tom Collins; Gregory R Moore Journal: J Rural Health Date: 2011-01-04 Impact factor: 4.333
Authors: Sharon J M Kessels; Helen S Marshall; Maureen Watson; Annette J Braunack-Mayer; Rob Reuzel; Rebecca L Tooher Journal: Vaccine Date: 2012-04-03 Impact factor: 3.641
Authors: Jessica Keim-Malpass; Emma M Mitchell; Pamela B DeGuzman; Mark H Stoler; Christine Kennedy Journal: Risk Manag Healthc Policy Date: 2017-03-13
Authors: Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; James A Singleton; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; Shannon Stokley Journal: MMWR Morb Mortal Wkly Rep Date: 2015-07-31 Impact factor: 17.586
Authors: Hansi Zhang; Christopher Wheldon; Adam G Dunn; Cui Tao; Jinhai Huo; Rui Zhang; Mattia Prosperi; Yi Guo; Jiang Bian Journal: J Am Med Inform Assoc Date: 2020-02-01 Impact factor: 4.497
Authors: Vivian Colón-López; Roxana Soto-Abreu; Diana T Medina-Laabes; Olga L Díaz-Miranda; Ana P Ortiz; Erick L Suárez; Pamela C Hull Journal: Hum Vaccin Immunother Date: 2021-08-09 Impact factor: 4.526